Macula and Retina Institute
Glendale, California, United States
Eye care center in Glendale, California
411 N Central Ave Suite 115, Glendale, CA 91203
About Macula and Retina Institute
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Jaeb Center for Health Research
5
Clearside Biomedical, Inc.
1
EyePoint Pharmaceuticals, Inc.
1
Paul Yates, MD, PhD
1
Clinical Trials at Macula and Retina Institute
During the past decade, Macula and Retina Institute conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on
average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
2013-02-01
2020-11-01
Completed
286
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO
2018-03-05
2018-12-18
Terminated
325
DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME
2017-12-07
2021-12-22
Completed
270
Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM
2022-02-22
2026-12-31
Recruiting
400
Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis
2022-06-06
2024-09-01
Recruiting
125
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Macula and Retina Institute"
#1 collaborator was "National Eye Institute (NEI)" with 3 trials as a collaborator, "National Institutes of Health (NIH)" with 3 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 2 trials as a collaborator, "CBCC Global Research" with 1 trials as a collaborator and "Kowa Company, Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Macula and Retina Institute
According to Clinical.Site data, the most researched conditions in "Macula and Retina Institute" are
"Diabetic Macular Edema" (2 trials), "Diabetic Retinopathy" (2 trials), "Epiretinal Membrane" (1 trials), "Geographic Atrophy" (1 trials) and "Macular Edema" (1 trials). Many other conditions were trialed in "Macula and Retina Institute" in a lesser frequency.
Clinical Trials Intervention Types at Macula and Retina Institute
Most popular intervention types in "Macula and Retina Institute" are "Drug" (7 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "2-mg Intravitreous Aflibercept Injection" (1 trials), "Bevacizumab + Deferred Aflibercept Group" (1 trials), "Deferred Vitrectomy" (1 trials) and "Fenofibrate" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Macula and Retina Institute
The vast majority of trials in "Macula and Retina Institute" are
8 trials for "All" genders.
Clinical Trials Status at Macula and Retina Institute
Currently, there are NaN active trials in "Macula and Retina Institute".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Macula and Retina Institute,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Macula and Retina Institute, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".